How PBPK Modeling Can Replace Drug-Drug Interaction Studies

Patients often take more than one drug at a time, especially elderly patients and those with complex diseases, such as cancer and neurological disorders. Therefore, it is crucial to determine what the potential risk might be of a new drug candidate interacting with existing marketed medications. …

Author(s): Karen Rowland Yeo, PhD

返回顶部
Powered by Translations.com GlobalLink OneLink Software